COO
Price
$92.49
Change
-$0.95 (-1.02%)
Updated
Dec 23, 04:59 PM (EDT)
66 days until earnings call
STE
Price
$207.93
Change
+$0.44 (+0.21%)
Updated
Dec 23, 04:59 PM (EDT)
44 days until earnings call
Ad is loading...

COO vs STE

Header iconCOO vs STE Comparison
Open Charts COO vs STEBanner chart's image
Cooper Companies (The)
Price$92.49
Change-$0.95 (-1.02%)
Volume$45.54K
CapitalizationN/A
STERIS
Price$207.93
Change+$0.44 (+0.21%)
Volume$500
CapitalizationN/A
COO vs STE Comparison Chart
Loading...
COO
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
STE
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
View a ticker or compare two or three
VS
COO vs. STE commentary
Dec 24, 2024

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is COO is a Hold and STE is a Hold.

COMPARISON
Comparison
Dec 24, 2024
Stock price -- (COO: $93.44 vs. STE: $207.49)
Brand notoriety: COO and STE are both not notable
Both companies represent the Medical Specialties industry
Current volume relative to the 65-day Moving Average: COO: 188% vs. STE: 194%
Market capitalization -- COO: $19.72B vs. STE: $22.22B
COO [@Medical Specialties] is valued at $19.72B. STE’s [@Medical Specialties] market capitalization is $22.22B. The market cap for tickers in the [@Medical Specialties] industry ranges from $3.82T to $0. The average market capitalization across the [@Medical Specialties] industry is $8.04B.

Long-Term Analysis

It is best to consider a long-term outlook for a ticker by using Fundamental Analysis (FA) ratings. The rating of 1 to 100, where 1 is best and 100 is worst, is divided into thirds. The first third (a green rating of 1-33) indicates that the ticker is undervalued; the second third (a grey number between 34 and 66) means that the ticker is valued fairly; and the last third (red number of 67 to 100) reflects that the ticker is undervalued. We use an FA Score to show how many ratings show the ticker to be undervalued (green) or overvalued (red).

COO’s FA Score shows that 0 FA rating(s) are green whileSTE’s FA Score has 1 green FA rating(s).

  • COO’s FA Score: 0 green, 5 red.
  • STE’s FA Score: 1 green, 4 red.
According to our system of comparison, STE is a better buy in the long-term than COO.

Short-Term Analysis

It is best to consider a short-term outlook for a ticker by using Technical Analysis (TA) indicators. We use Odds of Success as the percentage of outcomes which confirm successful trade signals in the past.

If the Odds of Success (the likelihood of the continuation of a trend) for each indicator are greater than 50%, then the generated signal is confirmed. A green percentage from 90% to 51% indicates that the ticker is in a bullish trend. A red percentage from 90% - 51% indicates that the ticker is in a bearish trend. All grey percentages are below 50% and are considered not to confirm the trend signal.

COO’s TA Score shows that 4 TA indicator(s) are bullish while STE’s TA Score has 4 bullish TA indicator(s).

  • COO’s TA Score: 4 bullish, 5 bearish.
  • STE’s TA Score: 4 bullish, 5 bearish.
According to our system of comparison, both COO and STE are a bad buy in the short-term.

Price Growth

COO (@Medical Specialties) experienced а -1.49% price change this week, while STE (@Medical Specialties) price change was -3.14% for the same time period.

The average weekly price growth across all stocks in the @Medical Specialties industry was -0.55%. For the same industry, the average monthly price growth was +0.22%, and the average quarterly price growth was +2.20%.

Reported Earning Dates

COO is expected to report earnings on Feb 27, 2025.

STE is expected to report earnings on Feb 05, 2025.

Industries' Descriptions

@Medical Specialties (-0.55% weekly)

Medical specialties are companies that make equipment used by the health care industry. Equipment manufactured and distributed by these companies include dialysis machines, blood analysis equipment, surgical equipment, dental instruments, and diagnostic tools, among other items. Large companies typically aim to produce and distribute high-quality products across a broad market spectrum. Smaller firms are more likely to specialize in a particular market segment. Due to the industry’s close association with medical treatments, they typically have low sensitivity to macroeconomic fluctuations. Within this industry, Abbott Laboratories, Medtronic Plc and Thermo Fisher Scientific Inc. are some of the companies with multi-billion market capitalizations in the U.S. stock markets.

SUMMARIES
Loading...
FUNDAMENTALS
Fundamentals
STE($22.2B) has a higher market cap than COO($19.7B). COO has higher P/E ratio than STE: COO (68.09) vs STE (38.85). COO YTD gains are higher at: -1.237 vs. STE (-4.717). STE has higher annual earnings (EBITDA): 1.39B vs. COO (895M). STE has more cash in the bank: 196M vs. COO (135M). COO has less debt than STE: COO (2.77B) vs STE (3.51B). STE has higher revenues than COO: STE (5.41B) vs COO (3.67B).
COOSTECOO / STE
Capitalization19.7B22.2B89%
EBITDA895M1.39B64%
Gain YTD-1.237-4.71726%
P/E Ratio68.0938.85175%
Revenue3.67B5.41B68%
Total Cash135M196M69%
Total Debt2.77B3.51B79%
FUNDAMENTALS RATINGS
COO vs STE: Fundamental Ratings
COO
STE
OUTLOOK RATING
1..100
5050
VALUATION
overvalued / fair valued / undervalued
1..100
90
Overvalued
16
Undervalued
PROFIT vs RISK RATING
1..100
6944
SMR RATING
1..100
8379
PRICE GROWTH RATING
1..100
6059
P/E GROWTH RATING
1..100
8674
SEASONALITY SCORE
1..100
7550

Tickeron ratings are formulated such that a rating of 1 designates the most successful stocks in a given industry, while a rating of 100 points to the least successful stocks for that industry.

STE's Valuation (16) in the Medical Specialties industry is significantly better than the same rating for COO (90). This means that STE’s stock grew significantly faster than COO’s over the last 12 months.

STE's Profit vs Risk Rating (44) in the Medical Specialties industry is in the same range as COO (69). This means that STE’s stock grew similarly to COO’s over the last 12 months.

STE's SMR Rating (79) in the Medical Specialties industry is in the same range as COO (83). This means that STE’s stock grew similarly to COO’s over the last 12 months.

STE's Price Growth Rating (59) in the Medical Specialties industry is in the same range as COO (60). This means that STE’s stock grew similarly to COO’s over the last 12 months.

STE's P/E Growth Rating (74) in the Medical Specialties industry is in the same range as COO (86). This means that STE’s stock grew similarly to COO’s over the last 12 months.

TECHNICAL ANALYSIS
Technical Analysis
COOSTE
RSI
ODDS (%)
Bullish Trend 4 days ago
63%
Bullish Trend 4 days ago
68%
Stochastic
ODDS (%)
Bullish Trend 4 days ago
60%
Bullish Trend 4 days ago
63%
Momentum
ODDS (%)
Bearish Trend 4 days ago
52%
Bearish Trend 4 days ago
64%
MACD
ODDS (%)
Bearish Trend 4 days ago
51%
Bearish Trend 4 days ago
55%
TrendWeek
ODDS (%)
Bearish Trend 4 days ago
57%
Bearish Trend 4 days ago
55%
TrendMonth
ODDS (%)
Bearish Trend 4 days ago
58%
Bearish Trend 4 days ago
50%
Advances
ODDS (%)
Bullish Trend 20 days ago
63%
Bullish Trend 19 days ago
58%
Declines
ODDS (%)
Bearish Trend 5 days ago
56%
Bearish Trend 5 days ago
50%
BollingerBands
ODDS (%)
Bullish Trend 4 days ago
62%
Bullish Trend 4 days ago
62%
Aroon
ODDS (%)
Bearish Trend 4 days ago
51%
Bearish Trend 4 days ago
48%
View a ticker or compare two or three
Ad is loading...
COO
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
STE
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
STOCK / NAMEPrice $Chg $Chg %
ISSC8.150.65
+8.67%
Innovative Solutions and Support
MPW3.860.10
+2.66%
Medical Properties Trust
ARCC21.380.25
+1.18%
Ares Capital Corp
NUS6.60-0.27
-3.93%
NuSkin Enterprises
ALZN1.11-0.14
-11.20%
Alzamend Neuro Inc.